Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1575 of 3499 entries
View as:

T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT03190967 Org: User:
Start: 04/18/18 End: 06/13/23 Due: 06/13/24

Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00020449 Org: User:
Start: 01/31/01 End: 05/31/04 Due: 05/31/05

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01660997 Org: User:
Start: 07/30/12 End: 03/11/14 Due: 03/11/15

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Phase: N/A Priority: Normal
NCT ID: NCT00001302 Org: User:
Start: 09/30/92 End: 06/30/02 Due: 06/30/03

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00032110 Org: User:
Start: 01/31/02 End: 05/31/07 Due: 05/31/08

Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002852 Org: User:
Start: 10/31/96 End: - Due: -

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Phase: N/A Priority: Normal
NCT ID: NCT02015104 Org: User:
Start: 12/18/13 End: 05/02/19 Due: 05/02/20

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT00674024 Org: User:
Start: 10/07/08 End: 01/22/13 Due: 01/22/14

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00118040 Org: User:
Start: 06/24/05 End: 08/15/10 Due: 08/15/11

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00033449 Org: User:
Start: 02/28/02 End: - Due: -

Collection of Transplant Stem Cells for Plasma Cell Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01547806 Org: User:
Start: 02/22/12 End: 01/11/18 Due: 01/11/19

SU6668 in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00024206 Org: User:
Start: 07/31/01 End: - Due: -

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT03278925 Org: User:
Start: 08/09/18 End: 12/31/24 Due: 12/31/25

Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT00085358 Org: User:
Start: 05/31/04 End: - Due: -

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02159989 Org: User:
Start: 06/18/14 End: 01/29/24 Due: 01/29/25

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Phase: N/A Priority: Normal
NCT ID: NCT01294358 Org: User:
Start: 01/26/11 End: 07/23/14 Due: 07/23/15

T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive

Phase: N/A Priority: Normal
NCT ID: NCT02111850 Org: User:
Start: 02/07/14 End: 03/24/21 Due: 03/24/22

Sun Exposure and Melanoma in Agricultural Workers

Phase: N/A Priority: Normal
NCT ID: NCT00901966 Org: User:
Start: 05/12/09 End: 02/13/13 Due: 02/13/14

Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00083122 Org: User:
Start: 04/30/04 End: 05/31/12 Due: 05/31/13

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04989283 Org: User:
Start: 09/09/21 End: 05/10/31 Due: 05/10/32

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003204 Org: User:
Start: 03/31/98 End: - Due: -

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01533181 Org: User:
Start: 02/29/12 End: 11/30/14 Due: 11/30/15

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Phase: N/A Priority: Normal
NCT ID: NCT03785210 Org: User:
Start: 06/05/19 End: 12/31/22 Due: 12/31/23

Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C

Phase: N/A Priority: Normal
NCT ID: NCT00040729 Org: User:
Start: 03/31/02 End: - Due: -

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05371054 Org: User:
Start: 04/05/23 End: 06/01/25 Due: 06/01/26